We compared cerebral blood flow (CBF) measured using computed tomographic (CT) perfusion (CTP) and N-isopropyl-p-[(123) I]-iodoamphetamine cerebral perfusion single-photon emission computed tomography (SPECT).
We used a 320-row area detector CT and N-isopropyl-p-[(123) I]-iodoamphetamine cerebral perfusion SPECT under similar conditions in patients with chronic cerebrovascular disease. Images were automatically aligned 3-dimensionally for voxel-by-voxel comparisons.
Linear positive correlations were observed between CTP-CBF including high-blood-flow areas and SPECT-CBF over the whole brain (r = 0.001–0.6, P < 0.01), superior cerebral level (r = 0.45–0.93, P < 0.01), basal ganglia level (r = 0.44–0.77, P < 0.01), and skull base (r = 0.02–0.66, P < 0.01). Correlations between CTP-CBF excluding high-blood-flow areas were significantly higher (P < 0.0001).
Computed tomographic perfusion overestimated CBF compared with SPECT and showed poor correlation at the skull base. Computed tomographic perfusion CTP excluding high-blood-flow areas improved the correlation over the whole brain in patients with chronic cerebrovascular disease.
From the *Department of Radiology and †Neurosurgery, Fujita Health University, Toyoake, Japan; ‡Division of Nuclear Medicine, Graduate School of Medicine, University of Tokyo, Japan; Software Development Group, Product Management and Marketing Department., Sales and Marketing Division, FUJIFILM RI Pharma Co., Ltd., Japan; §Clinical Application Research Center, Toshiba Medical Systems Corporation, Otawara, Japan; and ∥Joint Research Laboratory of Advanced Medical Imaging, Fujita Health University, Toyoake, Japan.
Received for publication January 8, 2014; accepted April 3, 2014.
Reprints: Kazuhiro Murayama, MD, PhD, Department of Radiology, Fujita Health University, 1-98 Dengakugakubo, Kutsukake-cho Toyoake, Aichi, 470–1101, Japan (e-mail: email@example.com).
KM has grant support from Toshiba Medical Systems Corporation. The remaining authors declare no conflict of interest.